Molecular characterization underlying IFN-α2 treatment in polycythemia vera: a transcriptomic overview

Area of Science:

• Hematology
• Molecular Biology
• Genomics

Background:

• Polycythemia vera (PV) is a common chronic myeloproliferative neoplasm (MPN).
• Pegylated interferon-α2 (IFN-α2) is an effective treatment for PV, but its mechanisms remain unclear.
• Understanding IFN-α2's molecular action is crucial for optimizing PV therapy.

Purpose of the Study:

• To identify genes and pathways affected by IFN-α2 treatment in PV.
• To elucidate the molecular mechanisms underlying IFN-α2's therapeutic effects in PV.
• To investigate how IFN-α2 impacts global gene expression in PV patients.

Main Methods:

• Weighted Gene Co-expression Network Analysis (WGCNA) and Limma algorithm were used to identify IFN-α2-sensitive genes and co-expression modules.
• Differential gene expression analysis compared PV patients to healthy controls and IFN-α2-treated PV patients.
• Threshold-free analysis compared global gene expression profiles across different groups.

Main Results:

• Identified IFN-α2-sensitive genes and four gene co-expression modules.
• Found 820 differentially expressed genes in PV compared to controls.
• Discovered that IFN-α2 treatment partially reversed PV-associated gene expression changes, particularly affecting metal ion homeostasis, metabolic processes, and the Jak-STAT pathway.

Conclusions:

• IFN-α2 treatment may alleviate PV progression by modulating multiple biological pathways.
• The study provides insights into the molecular basis of IFN-α2 therapy in PV.
• Findings contribute to a better understanding of PV pathogenesis and treatment.